N
NRSN
Neurosense Therapeutics Ltd
0.8046
+0.0996+14.13%After Hours: 0.8036 -0.0010 -0.12%19:39 06/18 EDT
OPEN/PREV CLOSE0.7500/0.7050
TODAY RANGE0.7400-0.8046
VOL241.04K
MARKET CAP28.44M
52 WEEK RANGE0.6300-2.520
AVG VOL (3M)143.97K
% TURNOVER0.68%
TURNOVER--
P/E (TTM)-1.8429
% RANGE9.16%
EPS(TTM)-0.4366
P/E(FORWARD)-2.0899
P/B-16.7975
BVPS-0.0479
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP19.25M
SHARES OUTSTANDING35.35M
NEXT EARNINGS07/30-08/03
FREE FLOAT23.93M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·06/11 13:22
NeuroSense Secures South Korean Patent for ALS Drug Candidate PrimeC
TipRanks·06/10 13:37
Roth MKM Keeps Their Buy Rating on Neurosense Therapeutics Ltd. (NRSN)
TipRanks·06/09 14:28
NeuroSense Therapeutics Wins Key Japanese Patent for ALS Drug PrimeC
TipRanks·06/09 13:19
NeuroSense granted Japanese patent for PrimeC novel composition in ALS
TipRanks·06/08 13:30
NeuroSense Therapeutics Advances Canadian Regulatory Talks on ALS Drug PrimeC
Benzinga·06/02 21:09
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·04/28 19:57
NeuroSense Secures Insider-Led $600,000 PIPE at Premium Share Price
PUBT·04/28 18:30
NeuroSense prices $600,000 private placement at $0.8 per share
PR Newswire·04/28 18:30
NeuroSense Announces Pricing of Insider-Led PIPE Financing
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.